Nonmyeloablative Stem Cell Transplantation Is an Effective Therapy for Refractory or Relapsed Hodgkin Lymphoma: Results of a Spanish Prospective Cooperative Protocol
Iván Alvarez(Hospital de Sant Pau), Jorge Sierra(Universitat Autònoma de Barcelona), Miguel Canales(Hospital Universitario La Paz), Guillermo Sanz(Instituto de Salud Carlos III), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), José M. Moraleda(Centro Regional de Hemodonación), D Rubio-Félix(Hospital Universitario Miguel Servet), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Javier de la Serna(Hospital Universitario 12 De Octubre), Josep‐María Ribera(Universitat Autònoma de Barcelona), Marı́a Dolores Caballero(Complejo Hospitalario de Salamanca), Reyes Arranz, Carmen Martı́nez(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), J Garcı́a-Conde(Hospital de Sant Pau), Álvaro Urbano-Ispizúa(University of St.Gallen)
Cited by 142
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k